Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
Investing personality Jim Cramer recently called Recursion Pharmaceuticals a meme stock. The facts don't back up that position, though. Recursion may not be a meme stock, but that doesn't make it a ...
Our critic Jason Farago shares what you shouldn’t miss in a bustling city that is best discovered at a leisurely pace. By Jason Farago A tech giant has teamed up with local artists, adding vibrant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback